Susquehanna Portfolio Strategies
DNA icon

Susquehanna Portfolio Strategies’s Ginkgo Bioworks DNA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
176,231
+49,511
+39% +$414K 0.03% 463
2026
Q1 		$777K Buy
126,720
+49,518
+64% +$412K 0.01% 679
2025
Q4 		$642K Sell
77,202
-31,780
-29% -$342K 0.01% 726
2025
Q3 		$1.59M Buy
+108,982
New +$1.3M 0.03% 560

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Susquehanna Portfolio Strategies's DNA Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Ginkgo Bioworks (DNA) stake by 39% in Q2 2026, buying an estimated $414K and bringing the position to 176,231 shares worth $1.75M. The position accounts for 0.03% of the portfolio, ranked #463.

Susquehanna Portfolio Strategies first reported a position in DNA in Q3 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Susquehanna Portfolio Strategies held 176,231 shares of Ginkgo Bioworks worth $1.75M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 49,511 Ginkgo Bioworks shares in Q2 2026, an estimated $414K.
  • Ginkgo Bioworks made up 0.03% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #463 holding.
  • Susquehanna Portfolio Strategies first reported a position in Ginkgo Bioworks in Q3 2025 and has held it in 4 quarters since.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.